BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38448199)

  • 1. Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in Switzerland.
    Tilen R; Berger C; Allemann S; Meyer Zu Schwabedissen H
    Arch Dis Child; 2024 Jun; 109(7):586-591. PubMed ID: 38448199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Authorized or Off-Label Use? A Structured Analysis of Summaries of Product Characteristics with Regard to Authorization in Pediatrics.
    Herzig M; Eisenhofer S; Ruschkowski M; Neubert A; Bertsche A; Bertsche T; Neininger MP
    Pharmaceut Med; 2024 May; 38(3):205-216. PubMed ID: 38555544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets.
    Weisbach L; Schuster AK; Hartmann M; Fromm MF; Maas R; Farker K
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.
    Shimazawa R; Kano Y; Ikeda M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00435. PubMed ID: 30455958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiepileptics in women of childbearing age and during pregnancy: comparison of specialized information with the current state of knowledge in Germany and Switzerland].
    Winterfeld U; Gotta V; Rothuizen LE; Panchaud A; Rossetti AO; Buclin T
    Nervenarzt; 2014 Jun; 85(6):738-46. PubMed ID: 24861194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More medicines for children: impact of the EU paediatric regulation.
    Nordenmalm S; Tomasi P; Pallidis C
    Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping medicinal product information: a before and after study exploring physicians' perspectives on the summary of product characteristics.
    Vromans L; Doyle G; Petak-Opel S; Rödiger A; Röttgermann M; Schlüssel E; Stetter E
    BMJ Open; 2013 Aug; 3(8):e003033. PubMed ID: 23965932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Fortschr Neurol Psychiatr; 2020 Mar; 88(3):152-169. PubMed ID: 31127605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
    Afentaki A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
    Weersink RA; Timmermans L; Monster-Simons MH; Mol PGM; Metselaar HJ; Borgsteede SD; Taxis K
    Front Pharmacol; 2019; 10():1031. PubMed ID: 31607904
    [No Abstract]   [Full Text] [Related]  

  • 13. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
    Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
    Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
    Tukayo BLA; Sunderland B; Parsons R; Czarniak P
    PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
    Beers E; Egberts TC; Leufkens HG; Jansen PA
    Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs.
    Haag S; Junge L; Lotz F; McGauran N; Paulides M; Potthast R; Kaiser T
    J Patient Rep Outcomes; 2021 Dec; 5(1):127. PubMed ID: 34874524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food-drug interactions in the summary of product characteristics of proprietary medicinal products.
    San Miguel MT; Martínez JA; Vargas E
    Eur J Clin Pharmacol; 2005 Apr; 61(2):77-83. PubMed ID: 15761758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How often do SmPCs Contain Contraindications and Special Warnings that are Specific for the Paediatric Population].
    Wimmer S; Rascher W; Neubert A
    Klin Padiatr; 2019 Jul; 231(4):191-198. PubMed ID: 31158911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.